RECRUITING

Wellness, Intervention Strategies and HIV Care

Description

This is a pilot trial designed to assess the feasibility and acceptability of an intervention aimed at improving adherence to antiretroviral therapy (ART), viral suppression, and engagement in HIV care. The intervention will address behavioral coping strategies, HIV care engagement behaviors, and substance use management.

Conditions

HIVSubstance Use Disorder (SUD)
Talk to us

Related Conditions:

HIVSubstance Use Disorder (SUD)

Study Overview

On this page

Study Details

Study overview

This is a pilot trial designed to assess the feasibility and acceptability of an intervention aimed at improving adherence to antiretroviral therapy (ART), viral suppression, and engagement in HIV care. The intervention will address behavioral coping strategies, HIV care engagement behaviors, and substance use management.

Wellness, Intervention Strategies and HIV Care

Wellness, Intervention Strategies and HIV Care

Condition
HIV
Intervention / Treatment

-

Contacts and Locations

Oakland

Oakland MWCCS Site Office, Oakland, California, United States, 94612

San Francisco

SF MWCCS Site Office, San Francisco, California, United States, 94115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Be at least 18 years of age
  • * Self-report biological characteristics consistent with the population under study
  • * Be HIV-positive
  • * Report use of at least one of the following substances in the last 90 days:
  • * Cannabis
  • * Methamphetamine
  • * Cocaine/crack
  • * Cocaine
  • * Heroin
  • * Non-prescribed opioids (e.g., fentanyl, morphine)
  • * Ecstasy
  • * Phencyclidine (PCP)
  • * Psychedelics (e.g., Lysergic acid diethylamide, mescaline, ketamine)
  • * Poppers (alkyl nitrites)
  • * Non-prescribed benzodiazepines (e.g., Valium, Xanax, Klonopin, Librium)
  • * Barbiturates
  • * Be English-speaking
  • * Be able and willing to provide informed consent
  • * Evidence of severe cognitive impairment or active psychosis that may impede ability to provide fully informed consent, determined by the research assistants and clinical supervisor(s)
  • * The research staff are trained on guidelines for identifying participants who exhibit signs of inability to meaningfully participate or provide consent due to mental illness or impairment

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Jennifer P Jain, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2026-03-30